Reply

K J Jones¹, E Bevilacqua^{2

3}, F R Grati⁴, M Schmid¹, J C Jani²

Affiliations

¹ Roche Sequencing Solutions, Inc., San Jose, CA, USA.
² Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
³ Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.
⁴ TOMA Advanced Biomedical Assays S.p.A, Impact Lab., Busto Arsizio, Italy.

Free article

Comment

K J Jones et al. Ultrasound Obstet Gynecol. 2021 Oct.

Free article

. 2021 Oct;58(4):646.

doi: 10.1002/uog.24752.

K J Jones¹, E Bevilacqua^{2

3}, F R Grati⁴, M Schmid¹, J C Jani²

¹ Roche Sequencing Solutions, Inc., San Jose, CA, USA.
² Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
³ Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.
⁴ TOMA Advanced Biomedical Assays S.p.A, Impact Lab., Busto Arsizio, Italy.

No abstract available

Comment on

Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
Bevilacqua E, Jani JC, Chaoui R, Suk EA, Palma-Dias R, Ko TM, Warsof S, Stokowski R, Jones KJ, Grati FR, Schmid M. Bevilacqua E, et al. Ultrasound Obstet Gynecol. 2021 Oct;58(4):597-602. doi: 10.1002/uog.23699. Ultrasound Obstet Gynecol. 2021. PMID: 34090308 Free PMC article.
Cell-free DNA screening for fetal 22q11.2 deletion: a targeted test or genome-wide methodology?
Jing XY, Li DZ. Jing XY, et al. Ultrasound Obstet Gynecol. 2021 Oct;58(4):644-646. doi: 10.1002/uog.24751. Ultrasound Obstet Gynecol. 2021. PMID: 34596306 No abstract available.

1. Bevilacqua E, Jani JC, Chaoui R, Suk EKA, Palma-Dias R, Ko TM, Warsof S, Stokowski R, Jones KJ, Grati FR, Schmid M. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort. Ultrasound Obstet Gynecol 2021; 58: 597-602.
1. Schindewolf E, Khalek N, Johnson MP, Gebb J, Coleman B, Crowley TB, Zackai EH, McDonald-McGinn DM, Moldenhauer JS. Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome. Am J Med Genet A 2018; 176: 1735-1741.
1. Guseh S, Wilkins-Haug L, Kaimal A, Dunn-Albanese L, Adams S, Carroll S, Discenza M, Dobson L, Brillinger M, Foster J, Gbur S, Green H, Herrig N, Mandigo C, Pacione M, Roberts P, Sassaman A, Steinberg K, Studwell C, Gray KJ. Utility of noninvasive genome-wide screening: a prospective cohort of obstetric patients undergoing diagnostic testing. Genet Med 2021; 23: 1341-1348.
1. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184.